Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : gsk
gsk
MAJ Il y a 5 ans
Open Randomised Comparison of Lamotrigine with Carbamazepine as Monotherapy in Patients with Partial SeizuresExtensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
gsk
MAJ Il y a 5 ans
A comparative, open-label, randomized, and controlled clinical efficacy trial for preview evaluation of the skin oiliness control for three cosmetics products
The objective of this study is to evaluate the clinical efficacy of three cosmetics to control skin oiliness through the measurement of the sebum amount in the skin (using sebumetry assessment). The ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
gsk
MAJ Il y a 5 ans
Repeated bioequivalence study of US 100 mg Lamictal® compressed tablets, US 100 mg Lamictal® dispersible/chewable tablets and UK 100 mg Lamictal® dispersible/chewable tablets in healthy adult male volunteers
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
gsk
MAJ Il y a 5 ans
Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
gsk
MAJ Il y a 5 ans
Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparation of Cephalexin 125 mg/ 5 ml (Ceporex® GlaxoSmithKline México, S.A. de C.V. vs. Keflex®, Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers
The objective of this study was to confirm if two formulations of cephalexin suspension are bioequivalent. Test product was Ceporex® (125 mg Cephalexin / 5 ml; GlaxoSmithKline) and reference product ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
gsk
MAJ Il y a 5 ans
Study in adults aged between 18 and 45 years to evaluate the reactogenicity and the immunogenicity of an experimental administration of GlaxoSmithKline Biologicals' Fluarix vaccine (known as a-Rix in Belgium). Standard intramuscular and subcutaneous vaccine administration will be used as references
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
gsk
MAJ Il y a 5 ans
A Prospective and Retrospective Observational Study of Real-World Treatment Patterns in Patients with HER2+Advanced or Metastatic Breast Cancer in Europe and the United States
Rationale: There is a paucity of real-world data on the current treatment patterns of human epidermal growth factor receptor 2 positive (HER2+) locally advanced breast cancer (LABC) or metastatic bre...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
gsk
MAJ Il y a 5 ans
Studies using DAD - Effects of different interventions to improve ART-associated dyslipidemia
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
gsk
MAJ Il y a 5 ans
Inflammatory mediator release from epithelial cells taken from Japanese COPD patients, smoking controls and non-smoking controls
Chronic obstructive pulmonary disease (COPD) is a long-term multifaceted inflammatory disease state that consists pathologically of chronic bronchitis, small airways disease and emphysema, which may o...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
gsk
MAJ Il y a 5 ans
A Randomized, Double-Blind, Placebo-Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder (GAD)
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant